Product Overview
Stravix® is a cryopreserved human placental tissue composed of umbilical amnion and Wharton’s jelly. Stravix retains the native collagen and hyaluronic acid-rich extracellular matrix (ECM), endogenous growth factors, and endogenous cells including epithelial cells, fibroblasts, and mesenchymal stem cells (MSCs) found in placental tissue.
Why Stravix?
Stravix is a living placental tissue for surgical applications. As a viable wrap for surgical procedures, Stravix conforms to injured tissue, can be sutured, and is arthroscopic and robotic procedure friendly. Stravix is manufactured using a proprietary process allowing the tissue to retain its native components.
Stravix Facts:
• Available in two sizes
• 2-year shelf life at -75°C to -85°C
• Minimal preparation required
• Durable, conforming, and easy to manipulate
• Defined as an HCT/P under Section 361 of the Public Health Service Act and 21 CFR Part 1271
Stravix preserves the native components of placental tissue:
• Viable endogenous cells
• Variety of endogenous growth factors, cytokines, and peptides
• Collagen and hyaluronic acid-rich ECM
Stravix can be used as a surgical covering or wrap for several procedures, including but not limited to:
• Tendon Repair
• Achilles Tendon Rupture
• Bunionectomy
• Hallux Rigidus Correction
• Foot Amputations
• Fibromatosis
• Arthrodesis
(http://www.osiris.com/)
